Cancer Family
Intestinal Neoplasm
CI-CAN-00000209Explore in graph →
Non-malignant1,893 active trials21 approved drugs383 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000209Explore in graph →
Clinical trials
9,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00230399 | Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 15 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT02419677 | Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases | completed | Phase 2 / Phase 3 | 60 | The First People's Hospital of ChangzhouOTHER | 1 | Apr 17, 2015 |
| NCT00032110 | Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00077298 | Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer | completed | Phase 2 | 70 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01916239 | Pomegranate Extract Supplementation in Colorectal Cancer Patients(POMEcolon) | completed | Phase 1 / Phase 2 | 60 | National Research Council, SpainOTHER_GOV | 1 | Apr 14, 2015 | clinicaltrials |
| NCT02415699 | DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer | unknown | Phase 2 / Phase 3 | 100 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 0 | Apr 14, 2015 | clinicaltrials |
| NCT02415829 | Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients | unknown | Phase 2 | 55 | Fudan UniversityOTHER | 1 | Apr 14, 2015 | clinicaltrials |
| NCT01941953 | Metformin and 5-fluorouracil for Refractory Colorectal Cancer. | completed | Phase 2 | 50 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Apr 8, 2015 | clinicaltrials |
| NCT01531777 | Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal Cancer | completed | Phase 2 | 40 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 3, 2015 | clinicaltrials |
| NCT01277406 | 4SC-201 (Resminostat) in Advanced Colorectal Carcinoma(SHORE) | completed | Phase 1 / Phase 2 | 17 | 4SC AGINDUSTRY | 1 | Apr 1, 2015 | clinicaltrials |
| NCT00551421 | Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 17 | National Cancer Institute (NCI)NIH | 1 | Mar 31, 2015 | clinicaltrials |
| NCT00958386 | Safety and Efficacy Study of Panitumumab+Irinotecan in Patients Wild-Type (WT) KRAS Metastatic Colorectal Cancer Refractory to Irinotecan Based Chemotherapy (SPECTRA)(SPECTRA) | completed | Phase 2 | 61 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT01071655 | Selecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer(SETICC) | completed | Phase 2 | 195 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT01126112 | Study of First-line Single-agent Panitumumab in Frail Elderly Patients With Advanced Wild Type K-RAS Colorectal Cancer(FRAIL) | completed | Phase 2 | 33 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT01215539 | Study of Panitumumab-Capecitabine-Oxaliplatin In Wild-Type K-Ras Metastatic Colorectal Cancer Patients | completed | Phase 2 | 78 | Hellenic Cooperative Oncology GroupOTHER | 1 | Mar 18, 2015 | clinicaltrials |
| NCT02075086 | Angiogenic Switch in Patients With Colorectal Cancer(ANGIOSWITCH) | unknown | Phase 2 | 100 | Grupo Hospital de MadridOTHER | 1 | Mar 17, 2015 | clinicaltrials |
| NCT00826579 | Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer | completed | Phase 1 / Phase 2 | 192 | University Hospital, Basel, SwitzerlandOTHER | 1 | Mar 12, 2015 | clinicaltrials |
| NCT02295930 | Induction Chemoterapy With Folfoxiri Plus Cetuxumab in Unresectable Colorectal Cancer Patient(MACBETH) | completed | Phase 2 | 143 | Gruppo Oncologico del Nord-OvestOTHER | 1 | Mar 12, 2015 | clinicaltrials |
| NCT01358812 | FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal Cancer(TRIP) | completed | Phase 2 | 37 | Gruppo Oncologico del Nord-OvestOTHER | 1 | Mar 11, 2015 | clinicaltrials |
| NCT01579357 | Pharmacokinetics and Metabolic Activation of Capecitabine | completed | Phase 2 | 24 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | Mar 9, 2015 | clinicaltrials |
| NCT00575640 | Hydralazine as a Demethylating Agent in Rectal Cancer | withdrawn | Phase 1 / Phase 2 | 0 | University of ArkansasOTHER | 0 | Mar 4, 2015 | clinicaltrials |
| NCT01547130 | Yoga and Bolus Lukewarm Saline as Rapid Colonoscopy Preparation | completed | Phase 1 / Phase 2 | 133 | Arya, Vijaypal, M.D., P.C.INDIV | 1 | Mar 4, 2015 | clinicaltrials |
| NCT02376452 | Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Mar 3, 2015 | clinicaltrials |
| NCT00103311 | SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer | completed | Phase 2 | 64 | National Cancer Institute (NCI)NIH | 1 | Mar 2, 2015 | clinicaltrials |
| NCT01135498 | A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer. | completed | Phase 2 | 90 | Hoffmann-La RocheINDUSTRY | 1 | Feb 6, 2015 | clinicaltrials |
| NCT00904839 | BIBF 1120 Versus Bevacizumab in Metastatic Colorectal Cancer | completed | Phase 2 | 128 | Boehringer IngelheimINDUSTRY | 5 | Feb 4, 2015 | clinicaltrials |
| NCT02195141 | Trial of Using SIB-IMRT in Preoperative Radiotherapy for Locally Advanced Rectum Cancer | unknown | Phase 2 | 104 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT01269216 | A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer | completed | Phase 2 | 136 | Yonsei UniversityOTHER | 1 | Jan 28, 2015 | clinicaltrials |
| NCT00660582 | FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor | completed | Phase 2 | 152 | Per PfeifferOTHER | 3 | Jan 21, 2015 | clinicaltrials |
| NCT01483001 | Feasibility Study on Stem Cells Sensitivity Assay(STELLA) | completed | Phase 2 | 23 | Associazione Oncologia TraslazionaleOTHER | 1 | Jan 14, 2015 | clinicaltrials |
| NCT00754494 | Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma | completed | Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Jan 6, 2015 | clinicaltrials |
| NCT01659424 | Phase II Trial of Preoperative High-dose-rate Endorectal Brachytherapy and FOLFOX Chemotherapy for Rectal Cancer(HDRBT) | withdrawn | Phase 2 | 0 | Beth Israel Medical CenterOTHER | 1 | Dec 18, 2014 | clinicaltrials |
| NCT01077739 | A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin | completed | Phase 2 | 75 | Hoffmann-La RocheINDUSTRY | 1 | Dec 15, 2014 | clinicaltrials |
| NCT00865709 | Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects | completed | Phase 2 | 198 | BayerINDUSTRY | 10 | Dec 11, 2014 | clinicaltrials |
| NCT00704600 | Nelfinavir, a Phase I/Phase II Rectal Cancer Study(Nelfinavir) | completed | Phase 1 / Phase 2 | 15 | Maastricht Radiation OncologyOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT01472770 | A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer(GemCaP) | completed | Phase 2 | 49 | Vejle HospitalOTHER | 1 | Dec 4, 2014 | clinicaltrials |
| NCT00376909 | A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women | completed | Phase 2 | 2,729 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT01889680 | Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal Cancer | withdrawn | Phase 2 | 0 | NSABP Foundation IncNETWORK | 0 | Dec 2, 2014 | clinicaltrials |
| NCT02288078 | Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402) | unknown | Phase 2 | 74 | Clinical Research Support Center KyushOTHER | 1 | Nov 13, 2014 | clinicaltrials |
| NCT01554059 | Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients(New Beat) | completed | Phase 2 | 25 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Nov 10, 2014 | clinicaltrials |
| NCT01413295 | Randomized Trial With Dendritic Cells in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 52 | Fundacion Clinic per a la Recerca BiomédicaOTHER | 1 | Nov 4, 2014 | clinicaltrials |
| NCT02280070 | RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301). | unknown | Phase 2 | 110 | Clinical Research Support Center KyushOTHER | 1 | Oct 31, 2014 | clinicaltrials |
| NCT01378143 | Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard Chemotherapy | completed | Phase 2 | 53 | Oncozyme Pharma Inc.INDUSTRY | 1 | Oct 21, 2014 | clinicaltrials |
| NCT02268006 | IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment(BISER) | unknown | Phase 2 | 50 | Institute of Oncology LjubljanaOTHER | 1 | Oct 20, 2014 | clinicaltrials |
| NCT02032485 | Near-Infrared Imaging of Peritoneal Carcinomatosis From Colorectal Cancer(OC-AP-ICG-IV) | completed | Phase 2 | 10 | Jules Bordet InstituteOTHER | 1 | Oct 15, 2014 | clinicaltrials |
| NCT00390364 | Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy | terminated | Phase 2 | 1 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 8, 2014 | clinicaltrials |
| NCT01149434 | Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers | terminated | Phase 1 / Phase 2 | 19 | University of UtahOTHER | 1 | Oct 6, 2014 | clinicaltrials |
| NCT00642746 | Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC) | terminated | Phase 2 | 16 | OHSU Knight Cancer InstituteOTHER | 1 | Sep 26, 2014 | clinicaltrials |
| NCT00589563 | Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer | completed | Phase 2 | 32 | City of Hope Medical CenterOTHER | 1 | Sep 10, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Apr 21, 2015source: clinicaltrials